Recombinant Staphylococcus aureus four-component vaccine (Escherichia coli)

重组金黄色葡萄球菌四组分疫苗（大肠杆菌）

Report date: 2025/07/22 09:58:21

Base Information

Drug NameRecombinant Staphylococcus aureus four-component vaccine (Escherichia coli)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsStaphylococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesJiangsu Kunli Biopharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Kunli Biopharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsStaphylococcal Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A